News

August 8, 2016August 8, 2016

MicroRNA May Offer Way to Control T-cells in RA and Other Autoimmune Diseases

News

An international collaboration involving researchers at The Scripps Research Institute (TSRI) unveiled the role a small molecule called microRNA-155 (miR-155) plays in our immune system, a finding that could help scientists develop novel therapies ... Read more

August 5, 2016August 5, 2016

Generic Biologic Drugs Appear Comparable to Brand-name Counterparts, According to Review

News

A new Johns Hopkins Bloomberg School of Public Health systematic review indicates that generic forms of a biologic drug for the treatment of rheumatoid arthritis and other autoimmune diseases seem ... Read more

August 3, 2016August 3, 2016

Novel Rheumatoid Arthritis Treatment Developed by BIOCAD

News

BIOCAD has advanced a novel medicine for autoimmune diseases that include rheumatoid arthritis (RA), and psoriatic arthritis (PsA). The company’s new drug candidate BCD-121 is forecast to increase the efficacy of RA treatment up to 20% compared with ... Read more

August 1, 2016August 1, 2016

Navidea’s Phase 1 Trial of Lymphoseek for Rheumatoid Arthritis Gets IRB Approval

News

The University of California, San Francisco School of Medicine has granted Institutional Review Board (IRB) approval to Navidea Biopharmaceuticals to conduct a Phase 1 clinical trial evaluating Lymphoseek (technetium Tc 99m tilmanocept) injection to ... Read more

July 29, 2016July 29, 2016

In Rheumatoid Arthritis Patients, Immunotherapy Appears to Reduce Cardiovascular Risk

News

Patients with rheumatoid arthritis (RA) treated with an immunotherapy of low-dose combination of two anticytokines have a reduced disease activity and a lower risk for cardiac events, according to researchers. These findings ... Read more

July 27, 2016July 27, 2016

Gut Bacteria Might Predict, Prevent Rheumatoid Arthritis Start, Severity

News

New studies suggest that bacteria in the gut may predict susceptibility to rheumatoid arthritis (RA), be used by physicians to prevent disease onset, and that altering the gut microbiome composition can improve RA ... Read more

July 25, 2016July 25, 2016

FDA-approved Orencia ClickJect for Rheumatoid Arthritis Launched by BMS

News

Bristol-Myers Squibb has launched its U.S. FDA-approved Orencia ClickJect Autoinjector for adults with moderate to severe rheumatoid arthritis (RA). Orencia (abatacept) is a modified antibody drug that interferes with the immune activity of T-cells and can treat the symptoms of rheumatoid ... Read more

July 22, 2016July 22, 2016

App Enables iPhone to Monitor Rheumatoid Arthritis Study Participants

News

Global pharmaceutical and healthcare products company GlaxoSmithKline (GSK) has launched the “Patient Rheumatoid Arthritis Data from the Real World” (PARADE) clinical study, using Apple iPhones to monitor activity and vital ... Read more

July 20, 2016July 20, 2016

Rheumatoid Arthritis Patients May See Improvement by Vagus Nerve Stimulation, Study Finds

News

Stimulating the vagus nerve with electrical signals significantly improves disease severity of rheumatoid arthritis (RA), according to a new study, “Vagus nerve stimulation inhibits cytokine production and attenuates disease severity ... Read more

July 15, 2016July 18, 2016

FDA Arthritis Advisory Committee Hears Perspectives on Biosimilar GP2015

News

The U.S. Food and Drug Administration (FDA) held Arthritis Advisory Committee Meetings, July 11-12 in Maryland, and discussed Biologics License Applications (BLA) approvals, including a submission for GP2015, Sandoz‘s proposed biosimilar product to Amgen’s drug ... Read more